condensates

Pfizer building
Biotech

Pfizer taps Dewpoint Therapeutics in $239M dystrophy drug deal

Fierce 15 winner Dewpoint Therapeutics has added Pfizer to its growing list of pharma partners looking to tap the startup’s next-gen condensate R&D.
Ben Adams Jan 6, 2021 8:08am
Scientists wearing lab coats and masks in a lab

With $81M Faze launch, the condensates field gathers steam

Dec 10, 2020 7:00am